BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 32388995)

  • 1. Mesoporous Silica-Coated Silver Nanoframes as Drug-Delivery Vehicles for Chemo/Starvation/Metal Ion Multimodality Therapy.
    Zhang Y; Li Y; Gao Z; Ding B; An P; Zhang X; Sun B; Sun B
    Langmuir; 2020 Jun; 36(23):6345-6351. PubMed ID: 32388995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational design of non-toxic GOx-based biocatalytic nanoreactor for multimodal synergistic therapy and tumor metastasis suppression.
    Hang L; Zhang T; Wen H; Li M; Liang L; Tang X; Zhou C; Tian J; Ma X; Jiang G
    Theranostics; 2021; 11(20):10001-10011. PubMed ID: 34815800
    [No Abstract]   [Full Text] [Related]  

  • 3. A pH-Responsive Charge-Convertible Drug Delivery Nanocarrier for Precise Starvation and Chemo Synergistic Oncotherapy.
    Zhou Y; Gao X; Lu Y; Zhang R; Lv K; Gong J; Feng J; Zhang H
    Chempluschem; 2023 Feb; 88(2):e202200394. PubMed ID: 36725346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocatalytic oncotherapy nanosystem with glucose depletion for the cascade amplification of hypoxia-activated chemotherapy and H
    Hu Y; Bai S; Fan X; Zhou F; Chen B; Tan S; Xu H; Pan A; Liang S; He Y
    Biomater Sci; 2022 May; 10(9):2358-2369. PubMed ID: 35383789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesoporous silica-coated gold nanoframes as drug delivery system for remotely controllable chemo-photothermal combination therapy.
    Gao Z; Shi T; Li Y; You C; Cheng K; Sun B
    Colloids Surf B Biointerfaces; 2019 Apr; 176():230-238. PubMed ID: 30623810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-accelerating H
    Tang Y; Ji Y; Yi C; Cheng D; Wang B; Fu Y; Xu Y; Qian X; Choonara YE; Pillay V; Zhu W; Liu Y; Nie Z
    Theranostics; 2020; 10(19):8691-8704. PubMed ID: 32754272
    [No Abstract]   [Full Text] [Related]  

  • 7. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
    Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X
    ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucose-responsive mesoporous silica nanoparticles to generation of hydrogen peroxide for synergistic cancer starvation and chemistry therapy.
    Du X; Zhang T; Ma G; Gu X; Wang G; Li J
    Int J Nanomedicine; 2019; 14():2233-2251. PubMed ID: 31118604
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
    Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
    ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iridium/ruthenium nanozyme reactors with cascade catalytic ability for synergistic oxidation therapy and starvation therapy in the treatment of breast cancer.
    Wei C; Liu Y; Zhu X; Chen X; Zhou Y; Yuan G; Gong Y; Liu J
    Biomaterials; 2020 Apr; 238():119848. PubMed ID: 32062149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hollow Mesoporous Silica Nanoparticles for Dual Chemo-starvation Therapy of Hepatocellular Carcinoma.
    Ullah A; Khan M; Yibang Z; Raza F; Hasnat M; Cao J; Qi X; Hussain A; Liu D
    Pharm Res; 2023 Sep; 40(9):2215-2228. PubMed ID: 37700104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the Therapeutic Efficiency of Hypoxic-Activated Prodrugs by Enhancing Hypoxia in Solid Tumors.
    Zhao G; Jin Y; Gao S; Xiao T; Fan M; Liu D; Zhang J; Li Z; Zhou X; Liu H
    ACS Biomater Sci Eng; 2022 Apr; 8(4):1604-1612. PubMed ID: 35348331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Starvation-amplified CO generation for enhanced cancer therapy via an erythrocyte membrane-biomimetic gas nanofactory.
    Wang Y; Liu Z; Wang H; Meng Z; Wang Y; Miao W; Li X; Ren H
    Acta Biomater; 2019 Jul; 92():241-253. PubMed ID: 31078766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pH-Triggered Controllable Release of Silver-Indole-3 Acetic Acid Complexes from Mesoporous Silica Nanoparticles (IBN-4) for Effectively Killing Malignant Bacteria.
    Kuthati Y; Kankala RK; Lin SX; Weng CF; Lee CH
    Mol Pharm; 2015 Jul; 12(7):2289-304. PubMed ID: 25996616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomimetic nanoreactor for targeted cancer starvation therapy and cascade amplificated chemotherapy.
    Shao F; Wu Y; Tian Z; Liu S
    Biomaterials; 2021 Jul; 274():120869. PubMed ID: 33984636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skillfully collaborating chemosynthesis with GOx-enabled tumor survival microenvironment deteriorating strategy for amplified chemotherapy and enhanced tumor ablation.
    Lu R; Zhou L; Liu Q; Wang S; Yang C; Hai L; Guo L; Wu Y
    Biomater Sci; 2021 Mar; 9(5):1855-1871. PubMed ID: 33464244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent Advances in Glucose-Oxidase-Based Nanocomposites for Tumor Therapy.
    Wang M; Wang D; Chen Q; Li C; Li Z; Lin J
    Small; 2019 Dec; 15(51):e1903895. PubMed ID: 31747128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pd@Pt-GOx/HA as a Novel Enzymatic Cascade Nanoreactor for High-Efficiency Starving-Enhanced Chemodynamic Cancer Therapy.
    Ming J; Zhu T; Yang W; Shi Y; Huang D; Li J; Xiang S; Wang J; Chen X; Zheng N
    ACS Appl Mater Interfaces; 2020 Nov; 12(46):51249-51262. PubMed ID: 33161703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Glucose/Oxygen-Exhausting Nanoreactor for Starvation- and Hypoxia-Activated Sustainable and Cascade Chemo-Chemodynamic Therapy.
    Guo Y; Jia HR; Zhang X; Zhang X; Sun Q; Wang SZ; Zhao J; Wu FG
    Small; 2020 Aug; 16(31):e2000897. PubMed ID: 32537936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Width-Consistent Mesoporous Silica Nanorods with a Precisely Controlled Aspect Ratio for Lysosome Dysfunctional Synergistic Chemotherapy/Photothermal Therapy/Starvation Therapy/Oxidative Therapy.
    Lu J; Liu F; Li H; Xu Y; Sun S
    ACS Appl Mater Interfaces; 2020 Jun; 12(22):24611-24622. PubMed ID: 32379418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.